Your browser doesn't support javascript.
loading
Generation of human induced pluripotent stem cell lines derived from four Rett syndrome patients with MECP2 mutations.
Mori, Miyu; Yoshii, Shoko; Noguchi, Michiya; Takagi, Daigo; Shimizu, Tomoya; Ito, Hidenori; Matsuo-Takasaki, Mami; Nakamura, Yukio; Takahashi, Satoru; Hamada, Hiromichi; Ohnuma, Kiyoshi; Shiohama, Tadashi; Hayashi, Yohei.
  • Mori M; iPS Cell Advanced Characterization and Development Team, BioResource Research Center, RIKEN, 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan; Department of Materials Science and Bioengineering, Nagaoka University of Technology, 1603-1 Kami-Tomioka, Nagaoka, Niigata 940-2188, Japan.
  • Yoshii S; Department of Pediatrics, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba, 260-0856, Japan.
  • Noguchi M; Cell Engineering Division, BioResource Research Center, RIKEN, 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan.
  • Takagi D; iPS Cell Advanced Characterization and Development Team, BioResource Research Center, RIKEN, 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan.
  • Shimizu T; iPS Cell Advanced Characterization and Development Team, BioResource Research Center, RIKEN, 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan.
  • Ito H; iPS Cell Advanced Characterization and Development Team, BioResource Research Center, RIKEN, 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan.
  • Matsuo-Takasaki M; iPS Cell Advanced Characterization and Development Team, BioResource Research Center, RIKEN, 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan.
  • Nakamura Y; Cell Engineering Division, BioResource Research Center, RIKEN, 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan.
  • Takahashi S; Department of Pediatrics, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa City, Hokkaido 078-8510, Japan.
  • Hamada H; Department of Pediatrics, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba, 260-0856, Japan.
  • Ohnuma K; Department of Materials Science and Bioengineering, Nagaoka University of Technology, 1603-1 Kami-Tomioka, Nagaoka, Niigata 940-2188, Japan; Department of Science of Technology Innovation, Nagaoka University of Technology, 1603-1 Kami-Tomioka, Nagaoka, Niigata 940-2188, Japan.
  • Shiohama T; Department of Pediatrics, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba, 260-0856, Japan. Electronic address: asuha_hare@chiba-u.jp.
  • Hayashi Y; iPS Cell Advanced Characterization and Development Team, BioResource Research Center, RIKEN, 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan. Electronic address: yohei.hayashi@riken.jp.
Stem Cell Res ; 77: 103432, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38703668
ABSTRACT
Rett syndrome is characterized by severe global developmental impairments with autistic features and loss of purposeful hand skills. Here we show that human induced pluripotent stem cell (hiPSC) lines derived from four Japanese female patients with Rett syndrome are generated from peripheral blood mononuclear cells using Sendai virus vectors. The generated hiPSC lines showed self-renewal and pluripotency and carried heterozygous frameshift, missense, or nonsense mutations in the MECP2 gene. Since the molecular pathogenesis caused by MECP2 dysfunction remains unclear, these cell resources are useful tools to establish disease models and develop new therapies for Rett syndrome.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Rett / Proteína 2 de Unión a Metil-CpG / Células Madre Pluripotentes Inducidas Límite: Female / Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Rett / Proteína 2 de Unión a Metil-CpG / Células Madre Pluripotentes Inducidas Límite: Female / Humans Idioma: En Año: 2024 Tipo del documento: Article